Associations between vitamin D, systemic inflammation and synbiotic supplementation: secondary study from a randomized clinical trial

Abstract

Purpose

To evaluate the effects of a synbiotic substance on the vitamin D (VitD) status of elderly, and its association with systemic inflammation. Research question: Is synbiotic supplementation able to improve the VitD status?

Methods

This is a secondary study from a randomized, parallel, double-blind controlled clinical trial, lasting 24 weeks, with 49 participants randomly assigned into two groups; the S-group received a synbiotic substance, and the P-group received placebo. Participants were evaluated at baseline and at the end of the study for body fat percentage (% fat); plasma levels of interleukin-10 (IL-10) and interleukin-6 (IL-6), obtaining the IL-10/IL-6 ratio, named anti-inflammatory index (AII); plasma markers of gut permeability; and plasma VitD concentration.

Results

None of the variables investigated presented significant differences between groups. However, the delta-value of VitD showed to be positive in S-group (which means that in average, this group increased this variable), while the delta value was reduced in S-group. The same behavior was observed with the AII values. From regression models, only the AII explained positively and significantly the final value of VitD.

Conclusions

We did not find significant effect of synbiotic supplementation on VitD status in community-dwelling elderly; the biomarkers of systemic inflammation explained the final values of VitD. Several uncertainties were observed in our study, especially regarding the ideal marker of gut permeability and the ideal measure of VitD. More studies are needed before drawing definitive conclusions.

This is a preview of subscription content, log in to check access.

Fig. 1

Abbreviations

%Fat:

body fat percentage

AII:

anti-inflammatory index

CAPES :

Coordination for the Improvement of Higher Education Personnel

CFU:

colony forming unit

DEXA:

dual-energy X-ray absorptiometry

FAPESP:

São Paulo Research Foundation

FM:

body fat mass

FOS:

fructooligosaccharide

HPLC:

high-performance liquid chromatography

iFABP:

intestinal fatty-acid binding protein

IL-10:

interleukin-10

IL-6:

interleukin-6

LPS:

lipopolysaccharide

NF:

nuclear factor

P:

group- placebo group

REBEC:

Brazilian Registration of Clinical Studies

S-group:

synbiotic group

SR:

systematic review

VDR:

vitamin D receptor

VitD:

Vitamin D (25OH)D3

VitDfin :

final values of VitD

VitDin :

initial values of VitD

Δ-value:

delta-value (difference between final and baseline results)

References

  1. 1.

    Chen Y, Du J, Zhang Z, Liu T, Shi Y, Ge X, et al. MicroRNA-346 mediates tumor necrosis factor alpha-induced downregulation of gut epithelial vitamin D receptor in inflammatory bowel diseases. Inflamm Bowel Dis. 2014;20:1910–8.

    Article  Google Scholar 

  2. 2.

    Matyjaszek-Matuszek B, Lenart-Lipińska M, Woźniakowska E. Clinical implications of vitamin D deficiency. Prz Menopauzalny. 2015;14:75–81.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. 3.

    Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med (Berl). 2010;88:441–50.

    CAS  Article  Google Scholar 

  4. 4.

    Lagishetty V, Misharin AV, Liu NQ, Lisse TS, Chun RF, Ouyang Y, et al. Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology. 2010;151:2423–32.

  5. 5.

    Yoon SS, Sun J. Probiotics, nuclear receptor signaling, and anti-inflammatory pathways (2011). Gastroenterol Res Pract. 2011;971938. https://doi.org/10.1155/2011/971938.

  6. 6.

    Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014;69:S4–9.

    Article  Google Scholar 

  7. 7.

    Franceschi C, Bonafé M, Valensin S, Olivieri F, De Luca M, Ottaviani E, et al. Inflamma-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244–54.

    CAS  Article  Google Scholar 

  8. 8.

    Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev. 2007;128:92–105.

  9. 9.

    Minciullo PL, Catalano A, Mandraffino G, Casciaro M, Crucitti A, Maltese G, et al. Inflammaging and anti-inflammaging: the role of cytokines in extreme longevity. Arch Immunol Ther Exp. 2016;64:111–26.

  10. 10.

    Manco M, Putignani L, Bottazzo GF. Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr Rev. 2010;31:817–44.

    CAS  Article  Google Scholar 

  11. 11.

    Pendyala S, Walker JM, Holt PR. A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology. 2012;142:1100–1.

    CAS  Article  Google Scholar 

  12. 12.

    Kamada N, Chen GY, Inohara N, Nuñez G. Control of pathogens and pathobionts by the gut microbiota. Nature Immunology. 2013;14:685–90.

    CAS  Article  Google Scholar 

  13. 13.

    Bakke D, Chatterjee I, Agrawal A, Dai Y, Sun J (2018). Regulation of microbiota by vitamin D receptor: a nuclear weapon in metabolic diseases. Nucl receptor res. 2018;pii: 101377.

  14. 14.

    Magrone T, Russo MA, Jirillo E. Role of immune cells in the course of central nervous system injury: modulation with natural products. Curr Pharm Des. 2016;22:701–8.

    CAS  Article  Google Scholar 

  15. 15.

    Melo AD, Silveira H, Luciano FB, Andrade C, Costa LB, Rostagno MH. Intestinal alkaline phosphatase: potential roles in promoting gut health in weanling piglets and its modulation by feed additives - a review. Asian-Australas J Anim Sci. 2016;29:16–22.

    CAS  Article  Google Scholar 

  16. 16.

    Carvalho CMR, Ribeiro SML. Aging, low-grade systemic inflammation and vitamin D. A mini-review Eur J Clin Nutr. 2017;71:434–40.

  17. 17.

    Douglas LC, Sanders ME. Probiotics and prebiotics in dietetics practice. J Am Diet Assoc. 2008;108:510–21.

  18. 18.

    Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–56.

    CAS  Article  Google Scholar 

  19. 19.

    Cohen J. Statistical power analysis for the behavior sciences. 2nd ed. Hillsdale, NJ: Erlbaum; 1988.

    Google Scholar 

  20. 20.

    Neto JV, de Melo CM, Ribeiro SM. Effects of three-month intake of synbiotic on inflammation and body composition in the elderly: a pilot study. Nutrients. 2013;5:1276–86.

    Article  Google Scholar 

  21. 21.

    Dirks NF, Ackermans MT, Lips P, de Jongh RT, Vervloet MG, de Jonge R, Heijboer AC (2018). The when, what & how of measuring vitamin D metabolism in clinical medicine. Nutrients 10(4). Pii: E482.

  22. 22.

    Tirang R, Neyestani AG, Kalayi A. Determination of serum 25-hydroxy cholecalciferol using high-performance liquid chromatography: a reliable tool for assessment of vitamin D status. Int J Vitam Nutr Res. 2007;77:341–6.

    Article  Google Scholar 

  23. 23.

    Laird E, Mcnulty H, Ward M, Hoev L, Mcsorlev E, Wallace JM, et al. Vitamin D deficiency is associated with inflammation in older Irish adults. J Clin Endocrin Metab. 2014;99:1807–15.

    CAS  Article  Google Scholar 

  24. 24.

    Wang TT, Dabbas B, Laperriere D, Bitton AJ, Soualhine H, Tavera-Mendoza LE, et al. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. J Biol Chem. 2010;285:2227–31.

  25. 25.

    Silva MC, Furlanetto TW. Does serum 25-hydroxyvitamin D decrease during acute-phase response? A systematic review. Nutr Res. 2015;35:91–6.

    CAS  Article  Google Scholar 

  26. 26.

    Galipeau HJ, Verdu EF. The complex task of measuring intestinal permeability in basic and clinical science. Neurogastroenterol Motil. 2016;28:957–65.

    CAS  Article  Google Scholar 

  27. 27.

    Derikx JP, Luyer MD, Heineman E, Buurman WA. Non-invasive markers of gut wall integrity in health and disease. World J Gastroenterol. 2010;16:5272–9.

    Article  Google Scholar 

  28. 28.

    Song WB, Lv YH, Zhang ZS, Li YN, Xiao LP, Yu XP, et al. Soluble intercellular adhesion molecule-1, D-lactate and diamine oxidase in patients with inflammatory bowel disease. World J Gastroenterol. 2009;15:3916–9.

  29. 29.

    Wang L, Llorente C, Hartmann P, Yang AM, Chen P, Schnabl B. Methods to determine intestinal permeability and bacterial translocation during liver disease. J Immunol Methods. 2015;421:44–53.

    CAS  Article  Google Scholar 

  30. 30.

    Grootjans J, Thuijls G, Verdam F, Derikx JP, Lenaerts K, Buurman WA. Non-invasive assessment of barrier integrity and function of the human gut. World J Gastrointest Surg. 2010;2:61–9.

    Article  Google Scholar 

  31. 31.

    Drincic AT, Armas LA, Vand Diest EE, Heaney RR. Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity (Silver Spring). 2012;20:1444–8.

    CAS  Article  Google Scholar 

  32. 32.

    Yiu JH, Dorweiler B, Woo CW. Interaction between gut microbiota and toll-like receptor: from immunity to metabolism. J Mol Med (Berl). 2017;95(1):13–20.

    CAS  Article  Google Scholar 

Download references

Acknowledgements

The supplements used in this experiment were donated by Invictus-Farmanutrição® exclusively for research purposes. We thank to Nicola A.C. Zorzetto, for the English review. The authors acknowledge the help of the students João Valentini Neto and Angelica M. de Pina Freitas in data collection.

Funding

The authors thank the Coordination for the Improvement of Higher Education Personnel (CAPES) - (Protocol no. 06/2011-Casadinho-PROCAD), and São Paulo Research Foundation (FAPESP) – Research Project no. 2012/15976-0.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Sandra Maria Lima Ribeiro.

Ethics declarations

Ethical standards

This study been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments; in addition, the study was approved by the Local Ethics in Human Research Committee (Process 200.870/2013). The procedures and the aim of the study were explained to the participants. While all the subjects were informed of the importance of remaining in the study for the entire 6 months, they were reassured of their right to withdraw from the study at any time. After the explanations, all the volunteers gave their informed consent prior to their inclusion in the study.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

de Carvalho, C.M.R.G., Luzia, L.A., Rondó, P.H. et al. Associations between vitamin D, systemic inflammation and synbiotic supplementation: secondary study from a randomized clinical trial. Nutrire 45, 4 (2020). https://doi.org/10.1186/s41110-019-0104-7

Download citation

Keywords

  • Vitamin D
  • Systemic inflammation
  • Aging
  • Synbiotic
  • Randomized double-blind clinical study